Colon Cancer Clinical Trial
Official title:
ERAS Lazio Network Clinical Registry
Enhanced recovery after surgery (ERAS) protocols are programs aiming to implement patients
recovery following surgical procedures developed about 25 years ago. ERAS protocols are based
on a multi-disciplinary approach encompassing surgery, anesthesiology, nutrition and nursing;
each specialty has to fulfill a number of items which have been demonstrated to reduce
morbidity rates, hospital stay and to implement functional recovery comparing standard
approach. Accordingly, ERAS society developed a Guidelines for a number of procedures,
including colorectal.
The aim of this study is to evaluate the adherence over the last years to these protocols in
eight Department of Surgery in Rome in a series of colorectal cancer patients.
Secondary aims are to investigate the correlation of the items adherence with surgical
outcome and to establish a network of hospitals aiming to promote ERAS approach on a regional
base.
Background. The acronym ERAS (Enhanced Recovery After Surgery) refers to a patient-centered,
evidence-based multi-disciplinary protocol designed to implement perioperative operation,
reduce surgical trauma, and facilitate recovery of physiological functions aiming to an early
hospital discharge.
Usually ERAS protocols give a continuum of care starting at home (pre-hospital/pre-admission
phase) to continue in followed by the pre-/ intra-/ and post-operative phases.
ERAS includes a wide range of disciplines and specialists, which focus on the needs of the
patient in order to improve support by facilitating his return home.
The first author to introduce the fast-track term in rectal surgery was Prof. Henrik Kehlet
in the mid-1990s, proposing a multi-modal rehabilitation program aimed to reduce
post-surgical stress response, morbidity, mortality and postoperative hospitalization. Since
then, a number of studies were conducted leading to the first ERAS protocol; since then,
these protocols were reviewed on a regular basis, the last time in 2017 and included in the
guidelines by the ERAS society (http://www.erassociety.org).
Currently, it is widely demonstrated that, comparing to a traditional approach, ERAS is
associated with a significant reduction in morbidity, days of hospitalization, mortality,
implementing early postoperative recovery with a consequent reduction of the costs, without
compromising patient safety.
In particular, ERAS for colorectal surgery, includes 24 demonstrated multi-disciplinary.
Aims. the investigators aim to evaluate the adherence to the individual items and the
short-term outcomes (postoperative hospitalization, complication rates within 30 days of
intervention, re-intervention) in a consecutive series of patients undergoing colorectal
resection, in eight centers in the Lazio region, treated according to the ERAS protocol.
Secondary aims are to investigate the correlation of the items adherence with surgical
outcome and to establish a network of hospitals aiming to promote ERAS approach on a regional
base.
Design. This is a no-profit, spontaneous, observational, non-intervention Audit collecting
data in eight surgical Departments based in Lazio region, since September 2014 to October
2017. Each participating center will be depositary of its own data.
Participating Centers.
1. UOC General Surgery 1, Fondazione Policlinico Universitario "A. Gemelli ", Rome
(Coordinator) -
2. Department of Surgery, S. Eugenio Hospital, Rome
3. UOD Week-Day Surgery, St. Andrea Hospital, Rome
4. UOC General Surgery, Polyclinic University Bio-Medical Campus, Rome
5. UO General and Urgent Surgery, Policlinico Casilino Hospital, Rome
6. UOC Surgery, San Paolo Hospital, Civitavechia (RM)
7. UOC General Surgery, Cristo Re Hospital, Rome
8. UOSD Robotic Surgery for General Surgery, San Giovanni-Addolorata Hospital, Rome
Data Collection. Each center will collect the data in a homogeneous Database. The data will
be collected in anonymous form and will be aimed at the definition of:
1. Duration of postoperative stay
2. Short-term morbidity rate (within 30 days) according to Clavien-Dindo classification
3. Re-intervention rate (within 30 days)
4. Hospital readmission (within 30 days)
f. Adherence rate to items of the series All data will be treated sensibly; each patient will
be recorded with a sequential center-specific code. For all new patients and for patients
seen in follow-up visits, the specific informed consent of the study will be compiled.
Statistical analysis. Categorical variables will be presented as rate and percentages, the
continuous variables as mean, median, and standard deviation.
A logistic regression will also be performed, computing items as co-variates, with the
end-point of post-operative morbidity and hospital stay.
Sample Size Calculation: 1000 patients, calculated on the basis of the annual case of each
participating center.
For the conduct and management of this observational study no additional cost will be charged
on NHS funds.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT03457454 -
Reducing Rural Colon Cancer Disparities
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03390907 -
Hybrid APC Assisted EMR for Large Colon Polyps
|
N/A | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT04079478 -
The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
|
||
Active, not recruiting |
NCT04057274 -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05147545 -
Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects
|
N/A | |
Recruiting |
NCT05026268 -
The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis
|
N/A | |
Not yet recruiting |
NCT03277235 -
Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Active, not recruiting |
NCT02730702 -
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
|
||
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02577627 -
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
|
N/A | |
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Recruiting |
NCT02526836 -
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
|
Phase 2/Phase 3 |